Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Research Grants 137 show all


$30.2M
2015

$31.1M
2016

$54.7M
2017

$27.2M
2018

$32.7M
2019

Patents 16,937show all

  • 3,398
    A61K - Preparations for medical, dental, or toilet purposes
  • 2,717
    C07K - Peptides
  • 2,176
    C12N - Microorganisms or enzymes
  • 1,916
    A61M - Devices for introducing media into, or onto, the body
  • 1,750
    C07D - Heterocyclic compounds
  • 966
    C11D - Detergent compositions
  • 787
    C12Y - Enzymes
  • 430
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 370
    C07C - Acyclic or carbocyclic compounds
  • 298
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 2,131show all

610N/A578Phase 3343Phase 1167Phase 4153Phase 210Other

Contact Information

Bagsværd
Denmark